| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-19 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-12 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |